Stay updated on GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial page.

Latest updates to the GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial page
- Check3 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed; no changes to core content or pricing are detected.SummaryDifference0.1%
- Check10 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%
- Check17 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as the introduction of topics related to drug safety and pathological conditions. Notably, previous topics on hypertension and related conditions have been removed.SummaryDifference2%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.6%
Stay in the know with updates to GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial page.